DongKook Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
16,764
20,997
27,625
40,693
40,868
Depreciation, Depletion & Amortization
5,190
4,360
5,656
5,741
7,337
Other Funds
173
1,680
510
1,204
1,987
Funds from Operations
21,674
29,751
38,162
51,546
47,271
Changes in Working Capital
871
6,091
10,258
11,262
17,940
Net Operating Cash Flow
20,804
23,660
27,904
40,284
29,331
Capital Expenditures
4,641
13,593
9,595
9,621
11,888
Sale of Fixed Assets & Businesses
5
45
15
28
561
Purchase/Sale of Investments
7,549
4,121
8,440
4,604
8,334
Net Investing Cash Flow
12,236
9,175
18,295
16,601
18,694
Cash Dividends Paid - Total
3,353
2,488
2,638
2,637
3,516
Issuance/Reduction of Debt, Net
489
2,482
2,326
2,876
3,540
Net Financing Cash Flow
2,804
1,151
960
4,309
3,188
Net Change in Cash
5,315
12,970
10,576
19,403
6,282
Free Cash Flow
16,810
10,074
18,838
30,814
17,657
Net Assets from Acquisitions
432
-
-
-
-
Other Sources
987
299
316
649
1,110
Change in Capital Stock
113
2,826
762
-
1,881
Exchange Rate Effect
448
363
7
28
1,167
Other Uses
606
48
591
3,053
143
About DongKook Pharmaceutical Co.
View Profile
